Application 021330
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE CONS
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NICORETTE | NICOTINE POLACRILEX | TROCHE/LOZENGE;ORAL | EQ 2MG BASE | Yes | No |
| 002 | NICORETTE | NICOTINE POLACRILEX | TROCHE/LOZENGE;ORAL | EQ 4MG BASE | Yes | Yes |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0135-0510 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0510 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0511 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0511 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0625 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0625 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0625 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0625 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0626 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0626 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0626 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0626 | NICORETTE | nicotine polacrilex | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |